AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 09, 2025

AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference

• Open a printable version of this page
• Email the URL of this page to a friend

NORTH CHICAGO, Ill., Jan. 9, 2025/PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Management will participate in a fireside chat at 10:15 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas - immunology, oncology, neuroscience, and eye care - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

SOURCE AbbVie

For further information: Media: Gabby Tarbert, (224) 244-0111, [email protected]; Investors: Liz Shea, (847) 935-2211, [email protected]